Soluble CD40 ligand and outcome in patients with coronary artery disease undergoing percutaneous coronary intervention
Fabio Angeli(University of Insubria), Claudio Cavallini, Rocco Sclafani, Clara Riccini, Paolo Verdecchia(Azienda Ospedaliera di Perugia), Sara Cavallini, Stefano Coiro(University of Perugia), Andrea Santucci(Misericordia University), Stefano Savonitto(Alessandro Manzoni Hospital), Stefano De Servi(University of Pavia)
Cited by 9
Related Papers
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
European Society of Hypertension Position Paper on Ambulatory Blood Pressure Monitoring
|Journal of Hypertension|2013|1.4k
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
|European Journal of Internal Medicine|2020|1.3k
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring
|Journal of Hypertension|2014|1k
Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
|Hypertension|2004|506